4.6 Article

Simultaneous determination of ranitidine and metronidazole in human plasma using high performance liquid chromatography with diode array detection

Journal

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 37, Issue 4, Pages 777-783

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jpba.2004.11.042

Keywords

ranitidine; metronidazole; reversed-phase chromatography; validation; plasma

Ask authors/readers for more resources

The development and validation of a simple method for the simultaneous determination of ranitidine and metronidazole in human plasma is described. Plasma samples (250 mu L) were deproteinized by precipitation with 60% perchloric acid, centrifuged and the supernatant directly injected into the HPLC. Separation was achieved in isocratic mode with a Shimpak C-18 column and a mobile phase consisting of 10 mM potassium dihydrogen phosphate pH 3.5:acetonitrile (90: 10, v/v) with UV detection at 315 nm. The method showed good selectivity and sensitivity. Good and consistent recovery for metronidazole and ranitidine was obtained: 96.22 +/- 3.52 and 95.00 +/- 4.50% for ranitidine (25-1000 ng/mL) and metronidazole (60-10,000 ng/mL), respectively (n = 3). With this one-step sample preparation method, both ranitidine and metronidazole could be quantified simultaneously in human plasma with good precision (R.S.D. < 15%) and accuracy (bias values below 15%). The limit of quantification for ranitidine and metronidazole were 20 and 40 ng/mL plasma, respectively. (c) 2004 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available